|
EP2540710A1
|
|
New precursors for direct radiosynthesis of protected derivatives of O-([18F]Fluoromethyl) tyrosine
|
|
UY33452A
|
|
REPLACED TRIAZOLOPIRIDINS
|
|
DE102011077065A1
|
|
Use of glucosidase inhibitors for producing topically applicable agents for prophylaxis of retroviral infections
|
|
TW201208707A
|
|
Method for production of f-18 labeled aβ ligands
|
|
AR081060A1
|
|
PROCEDURE TO PREPARE 4- {4 - [({[4-CHLORINE-3- (TRIFLUOROMETIL) PHENYL] AMINO} CARBONYL) AMINO] -3-FLUOROPHENOXY} -N-METHYLPIRIDIN-2-CARBOXAMIDE
|
|
WO2011095553A1
|
|
Sgc stimulators or sgc activators in combination with pde5 inhbitors for the treatment of erectile dysfunction
|
|
TN2011000058A1
|
|
Progestin-containing drug delivery system
|
|
TW201201846A
|
|
Iodo precursor for a PET imaging agent of amyloid plaques
|
|
DE102011003315A1
|
|
New 1H-pyrazolo(3,4-b)pyridine compounds are guanylate cyclase stimulators useful for treating and/or preventing e.g. heart failure, angina pectoris, hypertonia, pulmonary hypertonia, ischemia, vascular disease, and fibrotic disorder
|
|
WO2011092127A1
|
|
14,17-bridged estratriene derivatives comprising heterocyclic bioisosteres for the phenolic a-ring
|
|
TN2011000022A1
|
|
Estratriene derivatives comprising heterocyclic bioisosteres for the phenolic a - ring
|
|
DE102011002934A1
|
|
CB2 agonists for the treatment and prevention of endometriosis
|
|
TN2010000597A1
|
|
Substituted 7-sulfanylmethyl, 7-sulfinylmethyl and 7-sulfonylmethyl indoles and use thereof
|
|
TW201134512A
|
|
Dispenser for wafer-containing wafer pockets, and wafer pocket booklet
|
|
WO2011075727A1
|
|
Tear-away sheath with integral stop
|
|
TW201136609A
|
|
Compounds for imaging apoptotic cell death
|
|
DE102010063127A1
|
|
Liquid, orally administrable pharmaceutical compositions containing 5-chloro-N - ({(5S) -2-oxo-3- [4- (3-oxo-4-morpholinyl) -phenyl] -1,3-oxazolidin-5-yl } -methyl) -2-thiophenecarboxamide
|
|
TW201130854A
|
|
Pyridinone derivatives and pharmaceutical compositions thereof
|
|
TW201134485A
|
|
Anti-c4.4a antibodies and uses thereof
|
|
DE102010062544A1
|
|
New substituted 1-benzylcycloalkylcarboxylic acid compounds are soluble guanylate cyclase activators useful to treat and/or prevent e.g. heart failure, angina pectoris, hypertension, pulmonary hypertension and vascular disease
|
